The Role of Upadacitinib in Refractory Dermatomyositis: A Systematic Review
收藏官方服务：
资源简介：
Recent reports highlight upadacitinib, a JAK inhibitor that is highly selective for JAK1, as a promising treatment when used off-label for dermatomyositis. This systematic review aims to investigate upadacitinib as a therapy for refractory dermatomyositis.
提供机构：
Mendeley Data创建时间：
2025-05-14
